Experimental Hematology & Oncology

Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose

Mantle cell lymphoma and its management: where are we now?

Recent advances on blinatumomab for acute lymphoblastic leukemia

Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia

Targeted and novel therapy in advanced gastric cancer

The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis

NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children

Gut microbiome and CAR-T therapy

Novel GTF2I–PDGFRB and IKZF1–TYW1 fusions in pediatric leukemia with normal karyotype

An expanded biomarker panel for the detection of prostate cancer from urine DNA

Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation

Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

Frontline therapies for untreated chronic lymphoid leukemia

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma

Role of some members of chemokine/cytokine network in the pathogenesis of thalassemia and sickle cell hemoglobinopathies: a mini review

Immune pressures drive the promoter hypermethylation of neoantigen genes

Development of molecular and pharmacological switches for chimeric antigen receptor T cells

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma

A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker

Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort

LY86, LRG1 and PDE9A genes overexpression in umbilical cord blood hematopoietic stem progenitor cells by acute myeloid leukemia (M3) microvesicles

Thyroid dysfunction from inhibitor of fibroblast growth factor receptor

The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016

Cabozantinib and apixaban: an hitherto unreported interaction

Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)